Patents Assigned to Poxel SAS
  • Combination of triazine derivatives and insulin sensitisers
    Patent number: 8791115
    Abstract: The present invention relates to combinations of triazine derivatives and of insulin sensitizers.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: July 29, 2014
    Assignee: Poxel SAS
    Inventors: Gérard Moinet, Daniel Cravo, Didier Mesangeau
  • COMBINATION OF TRIAZINE DERIVATIVES AND INSULIN SENSITISERS
    Publication number: 20140050786
    Abstract: The present invention relates to combinations of triazine derivatives and of insulin sensitisers.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 20, 2014
    Applicant: POXEL SAS
    Inventors: Gerard MOINET, Daniel CRAVO, Didier MESANGEAU
  • Method for the production of 3,6-dihydro-L, 3, 5-triazine derivatives from metformin and paraldehyde derivatives
    Patent number: 8461331
    Abstract: Process for the preparation of compounds of the formula I in which R1, R2, R3, R4, R5 and R6 have the meanings indicated in claim 1, which comprises the reaction of a compound of the formula II in which R1, R2, R3, R4 have the meanings indicated above, with a compound of the formula III in which R5, R6 have the meanings indicated above.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: June 11, 2013
    Assignee: Poxel SAS
    Inventors: Matthias Helmreich, Mike Brandner
  • Combination of triazine derivatives and insulin secretion stimulators
    Patent number: 8227465
    Abstract: The present patent application relates to novel combinations of a triazine derivative and of an insulin secretion stimulator.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: July 24, 2012
    Assignee: Poxel SAS
    Inventors: Gérard Moinet, Daniel Cravo, Didier Mesangeau
  • Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect
    Patent number: 8217040
    Abstract: The present patent application relates to the use of triazine derivatives as cicatrising or angiogenic agents.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: July 10, 2012
    Assignee: Poxel SAS
    Inventors: Gérard Moinet, Daniel Cravo